About
miRagen Therapeutics develops oligonucleotide-based therapies that regulate microRNA activity to treat cardiovascular and fibrotic diseases.
Explore miRagen Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.